Pneumococcal Vaccine for 65+ in Korea: The Free PPSV23 Shot, When to Ask About PCV, and Pairing It With Your Flu Jab
Haesul Health desk (AI-assisted). As of 12 November 2026 (KST). Based on the Korea Disease Control and Prevention Agency (KDCA) Immunization Helper page on the national pneumococcal programme for adults 65 and over, the Government24 service page for the same programme, KDCA notices on Korea.kr (including the 2027 budget proposal summary of 5 November 2026) and the KDCA flu-vaccination page. Independent cross-checks: the Korean Society of Infectious Diseases (KSID) 2026 adult pneumococcal recommendations and vaccination Q&A, the US Centers for Disease Control and Prevention (CDC), and reporting by Maeil Business Newspaper and Uisinmun (bosa.co.kr). This is general information, not medical advice. Which vaccine suits you depends on your health and vaccination history; decide it with a doctor.
Quick answer: Korea’s national programme gives everyone aged 65 or over (for 2026, anyone born on or before 31 December 1961) one free dose of the 23-valent polysaccharide pneumococcal vaccine (PPSV23), all year round, at public health centres and designated clinics. If you already had PPSV23 at 65 or older, you don’t need another; if you had it before 65, KDCA says to ask a doctor about a further dose. The newer conjugate vaccines (PCV20, PCV21, or PCV15 followed by PPSV23) are what Korea’s infectious-disease society now recommends for 65+, but in 2026 they are paid out of pocket. KDCA’s 2027 budget proposal would switch the free 65+ shot from PPSV to PCV (₩41.8 billion), subject to the National Assembly. Pneumococcal and flu vaccines can be given on the same day, in different arms, so the free flu shot (running to 30 April 2027) is a good moment to ask.
Pneumonia season and flu season overlap, and many families checking a parent’s flu shot this month find the clinic also asking: “Has your mother had the pneumonia vaccine?” This guide explains what the free shot is, who gets it, how it differs from the conjugate vaccines you may be offered for a fee, what the 2027 plan says, and how to combine it with the flu jab.

What the free 65+ shot is, and who gets it
KDCA’s Immunization Helper page (last reviewed 5 January 2026) describes the national programme: to prevent invasive pneumococcal disease in people 65 and over, the state pays for one dose of PPSV23 at a nearby designated clinic, at no cost to you (KDCA Immunization Helper, 65+ pneumococcal programme). The Government24 service page for the same programme, updated 19 October 2026, gives the same rules (Government24):
| Rule | What KDCA / Government24 say |
|---|---|
| Who | Adults 65 and over who have not had PPSV23 at age 65 or older; for 2026, born on or before 31 December 1961 (judged by birth date on the resident registration) |
| What | PPSV23, one dose, paid by the state |
| When | All year (not tied to the flu season) |
| Where | Public health centres (including branches and rural health posts) and designated clinics (위탁의료기관); a non-designated clinic cannot give it free |
| Already had PPSV23 at 65+ | No further dose needed (and no subsidy for another) |
| Had PPSV23 before 65 | Talk to a doctor about an additional dose |
| Bring | ID |
Two practical notes from the same pages. Government24 and KDCA’s January notice on Korea.kr both warn that some public health centres do not vaccinate, depending on the local government, so call first (KDCA via Korea.kr, 6 January 2026). And KDCA tells older adults with underlying conditions to discuss the choice of vaccine (“polysaccharide or conjugate”) and its timing with the doctor at the pre-vaccination check.
Why it matters at 65
KDCA’s page says invasive pneumococcal disease is more frequent in people 65 and over, and that in older adults the death rate reaches 60% for bacteraemia and 80% for meningitis caused by pneumococcus. KSID’s 2026 recommendations, citing national surveillance, report 451 invasive cases in 2024, with 64.5% in people 60 or older, an overall case-fatality rate of 19.3%, and about 90% of deaths in people 60 or older (KSID 2026 adult recommendations). KSID also notes that cumulative PPSV23 coverage among people 65 and over was 78.5% in 2020, so roughly one older adult in five had not had it at that point.

PPSV23 versus the conjugate vaccines (PCV)
There are two families of pneumococcal vaccine. The difference explains why your doctor may mention a vaccine that isn’t free.
| PPSV23 (polysaccharide) | PCV20 / PCV21 (conjugate) | PCV15 + PPSV23 | |
|---|---|---|---|
| Doses for a healthy 65+ adult | 1 | 1 | PCV15, then PPSV23 at least 1 year later |
| Free under Korea’s 2026 programme? | Yes (once, at 65+) | No, paid | PPSV23 part free if not yet had at 65+; PCV15 paid |
| KSID 2026 recommendation for 65+ | Part of the PCV15 route | Recommended (either one) | Recommended |
| CDC (US) adults 50+ | Only after PCV15 | Recommended; no PPSV23 needed afterwards | Recommended |
Sources: KDCA Immunization Helper; KSID 2026 recommendations; CDC pneumococcal vaccine recommendations (25 February 2026).
KSID’s 2026 recommendations say all adults 65 and over (and high-risk adults aged 19 to 64) should get one of three options: PCV21 once, PCV20 once, or PCV15 followed by PPSV23, and it lists the three with no preference, because each was approved on immune-response data rather than head-to-head proof of fewer infections. The CDC’s adult guidance (updated 25 February 2026) gives the same three options for adults 50 and over and adds that after PCV20 or PCV21 no PPSV23 dose is needed (CDC). KSID keeps Korea’s age-based threshold at 65, saying the evidence for 50 to 64 in Korea is not yet enough.
Already had the free PPSV23? KSID’s table says a 65+ adult who has had PPSV23 only can get PCV21, PCV20 or PCV15 at least one year after the last PPSV23. Getting the free shot now therefore doesn’t rule out a conjugate vaccine later. In 2026 that later dose is paid, so ask the clinic for its price; it is a non-covered item and fees vary.
Who should ask specifically about PCV? KDCA’s own wording points to adults with underlying conditions. KSID’s high-risk list includes chronic illness, a weakened immune system, a missing or non-working spleen, a cochlear implant and a cerebrospinal-fluid leak; for some of these, the PCV15-then-PPSV23 gap can be as short as 8 weeks. Those are questions for the doctor, not a reason to skip the free dose while you wait.

The 2027 plan: free conjugate vaccine for 65+
KDCA’s summary of its 2027 budget proposal, published on Korea.kr on 5 November 2026, lists “65+ pneumococcal vaccination: ₩41.8 billion, (current) polysaccharide vaccine (PPSV) → (change) conjugate vaccine (PCV)” (KDCA via Korea.kr, 5 November 2026). Maeil Business Newspaper reported on 1 September 2026, when the cabinet approved the proposal, that the pneumococcal budget would rise from ₩13.6 billion to ₩41.8 billion (Maeil Business, 1 September 2026).
What is not settled yet, as of 12 November 2026:
- It is a proposal. The National Assembly still has to pass the 2027 budget.
- Which PCV, from when, and for whom have not been announced on KDCA’s programme page, which still describes PPSV23. Uisinmun reported in August that the KDCA commissioner told the National Assembly the plan is being prepared for people newly turning 65 and those never vaccinated. That is a single press report; treat it as a direction, not a rule.
Should a parent who turned 65 this year wait for 2027? We can’t answer that for any individual. What the sources do establish: the free PPSV23 is available now, all year; KSID allows a conjugate vaccine one year after PPSV23; and nobody has yet said whether people who had PPSV23 in 2026 would qualify for a free PCV in 2027. Ask the doctor, especially if your parent has a chronic condition.

Pairing it with the flu shot
The free 2026–27 flu shot for 65+ started on 6 October (75 and over), 12 October (70 to 74) and 15 October (65 to 69) and runs to 30 April 2027: one dose of trivalent inactivated vaccine at designated clinics and public health centres, wherever you are registered (KDCA Immunization Helper, flu for older adults; KDCA via Korea.kr, 22 September 2026). Our flu and COVID-19 vaccine guide covers that programme in full.
Can the two be given together? KSID’s vaccination Q&A says most vaccines can be given on the same day at different sites without reduced protection or more side effects. They must not be mixed in one syringe; if two go in the same limb they should be at least 2.5 cm (1 inch) apart; and between two inactivated vaccines given on different days there is no required gap (KSID vaccination Q&A). Korean health-industry reports this October said KDCA’s vaccination guidance allows pneumococcal and flu vaccines on the same day (read via press reports, not the guidance itself).
A visit plan that works for many families:
- Check the record first. The KDCA Immunization Helper site has a vaccination-record lookup (log in with identity verification), so you can see whether PPSV23 was already given and when.
- Find a designated clinic on the same site and phone to confirm it has PPSV23 in stock and does the flu shot too; KDCA notes stock figures online can differ from the shelf.
- Go on a day your parent feels well. A doctor’s pre-vaccination check is required; mention chronic illnesses and medicines.
- Ask the question directly: “Free PPSV23 today, or is a conjugate vaccine better for her?”
- Stay 20 to 30 minutes after the injections, as KDCA advises, then rest; KDCA suggests no alcohol or hard exercise that day.
If your parent is also considering the shingles vaccine, KSID’s Q&A notes that an old product-label caution about giving it with PPSV23 was not borne out by later studies. Our shingles vaccine guide covers costs and types; that vaccine is not free nationally.

For people with lung conditions
If a checkup lung-function test at 66 came back “suspected”, KDCA’s advice for reduced lung function includes flu, COVID-19 and pneumococcal vaccines for people 65 and over; our guide to the checkup lung function test at 56 and 66 explains the result sheet. That is one more reason to bring the result sheet to the vaccination visit.

Related reading
- South Korea COVID and flu vaccines 2026: who can get them and start dates
- Shingles vaccine in Korea: cost, types and who pays (age 50+)
- Korea’s checkup lung function test at 56 and 66
Frequently asked questions
Q. Who gets the free pneumococcal vaccine in Korea in 2026?
Adults 65 and over, which for 2026 means anyone born on or before 31 December 1961, who have not had PPSV23 at age 65 or older. They get one free dose of PPSV23 at a public health centre or designated clinic, at any time of year.
Q. My father had a pneumonia shot at 63. Does he get another one free?
KDCA and Government24 say that if PPSV23 was given before 65, you should talk to a doctor about an additional dose. If it was given at 65 or older, no further PPSV23 is needed and another one is not subsidised.
Q. Is the conjugate vaccine (PCV20 or PCV21) free?
Not in 2026; it is paid out of pocket and prices vary by clinic. KDCA’s 2027 budget proposal would switch the free 65+ vaccine from PPSV to PCV, but it still needs the National Assembly’s approval and the details have not been announced.
Q. Can my mother get the flu shot and the pneumococcal shot on the same day?
Generally yes. KSID says most vaccines can be given on the same day at different sites, not mixed in one syringe, and press reports say KDCA’s guidance allows this pairing. The doctor at the pre-vaccination check makes the final call.
Q. If she gets the free PPSV23 now, can she still have a PCV later?
Under KSID’s 2026 recommendations, an adult 65 or over who has had only PPSV23 can get PCV21, PCV20 or PCV15 at least one year after the last PPSV23. Whether a later PCV would be free under the 2027 plan has not been announced.
Sources
- Korea Disease Control and Prevention Agency (KDCA), Immunization Helper, 65세 이상 성인 폐렴구균 국가예방접종 (last reviewed 5 January 2026): PPSV23 one dose, born on or before 31 December 1961 for 2026, no further dose if given at 65+, all year, public health centres and designated clinics only, bacteraemia 60% / meningitis 80% death rates, discuss vaccine choice if underlying conditions, stay 20–30 minutes — https://nip.kdca.go.kr/irhp/infm/goVcntInfo.do?menuCd=135&menuLv=1 (read 12 November 2026)
- Government24, 65세 이상 폐렴구균 국가예방접종사업 (updated 19 October 2026; KDCA immunization management division): eligibility, PPSV23 before 65 → consult doctor, ID, check health centre first — https://www.gov.kr/portal/service/serviceInfo/SD0000016141 (read via search extract, 12 November 2026)
- KDCA via Korea.kr, 65세 이상 폐렴구균 국가예방접종 안내, 6 January 2026 — https://www.korea.kr/news/policyNewsView.do?newsId=148957567 (read via search extract, 12 November 2026)
- KDCA via Korea.kr, 2027년 질병관리청 예산안 핵심 내용, 5 November 2026 (65+ pneumococcal ₩41.8 billion, PPSV → PCV) — https://www.korea.kr/multi/visualNewsView.do?newsId=148975074 (read 12 November 2026)
- KDCA Immunization Helper, 2026–2027 flu programme for older adults (75+ from 6 October, 70–74 from 12 October, 65–69 from 15 October, to 30 April 2027; trivalent inactivated, once) — https://nip.kdca.go.kr/irhp/infm/goVcntInfo.do?menuCd=134&menuLv=1 (read via search extract, 12 November 2026); KDCA via Korea.kr, 22 September 2026 — https://www.korea.kr/news/policyNewsView.do?newsId=148972343
- Independent: Korean Society of Infectious Diseases, 성인 폐렴사슬알균 예방접종 권고안 (2026 revision): PCV21, PCV20 or PCV15→PPSV23 for 65+, equal preference; PPSV23-only → PCV after 1 year; 8-week interval for some high-risk groups; IPD 2024 451 cases, 60+ 64.5%, CFR 19.3%; PPSV23 coverage 78.5% (2020) — https://www.ksid.or.kr/introduce/file/vaccine_rule_2026_02.pdf (read via search extract, 12 November 2026)
- Independent: Korean Society of Infectious Diseases, adult vaccination Q&A (same-day administration at different sites, 2.5 cm rule, no interval between inactivated vaccines, zoster and PPSV23) — https://www.ksid.or.kr/file/qna.pdf (read 12 November 2026)
- Independent: CDC, Pneumococcal Vaccine Recommendations (25 February 2026): PCV15, PCV20 or PCV21 for adults 50+; PPSV23 one year after PCV15; none after PCV20/PCV21 — https://www.cdc.gov/pneumococcal/hcp/vaccine-recommendations/index.html (read 12 November 2026)
- Independent: Maeil Business Newspaper, 1 September 2026 (KDCA 2027 budget; pneumococcal ₩13.6 billion → ₩41.8 billion; PPSV23 → PCV) — https://www.mk.co.kr/news/society/12141561 (read 12 November 2026)
- Independent: Uisinmun (bosa.co.kr), 19 August 2026 (KDCA commissioner on a 2027 PCV programme for new 65-year-olds and the never-vaccinated; PCV currently non-covered) — https://www.bosa.co.kr/news/curationView.html?idxno=3010455 (read via search extract, 12 November 2026)
- Press reports of KDCA guidance on same-day flu and pneumococcal vaccination: Korea Medical & Pharmaceutical News, 6 October 2026 — http://www.kmpnews.co.kr/news/articleView.html?idxno=73500 (read via search extract; based on a vaccine maker’s release)
This article is general health information, not medical advice. It does not tell you which vaccine you or your parent should have. Discuss vaccination history, chronic conditions, allergies and medicines with the doctor at the pre-vaccination check.